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Abstract
Purpose: Previously we showed that mild thermal stress increased natural killer (NK) cell-
mediated tumour cytotoxicity and that this could be blocked by anti-NKG2D or anti-MICA
(major histolocompatability complex (MHC) class I related chain A) antibodies. Here, we
investigated the role of the transcription factor heat shock factor 1 (HSF1) in thermal regulation
of MICA expression in tumour cells in vitro and in vivo.
Materials and methods: Hyperthermia experiments were conducted in vitro and in mice using a
target temperature of 39.5 C. Apoptotic cells and NK cells in situ were visualised by use of the
TUNEL assay or expression of NKp46 respectively. Using Colo205 cells, HSF1 message was
blocked utilising siRNA while luciferase reporter assays were used to measure the activity of the
MICA promoter in vitro. Cell surface MICA was measured by flow cytometry.
Results: Following whole body hyperthermia (WBH), tumour tissues showed an increase in NK
cells and apoptosis. Mild thermal stress resulted in a transient increase in surface MICA and
enhanced NK cytotoxicity of the Colo205 colon cancer cell line. Silencing (mRNA) HSF1
expression in Colo205 cells prevented the thermal enhancement of MICA message and surface
protein levels, with partial loss of thermally enhanced NK cytotoxicity. Mutations of the HSF1
binding site on the MICA promoter implicated HSF1 in the thermal enhancement of MICA.
Some, but not all, patient-derived colon tumour derived xenografts also exhibited an enhanced
MICA message expression after WBH.
Conclusions: Up-regulation of MICA expression in Colo205 cells and enhanced sensitivity to NK
cell killing following mild thermal stress is dependent upon HSF1.
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Introduction
Natural killer (NK) cells are immune effector cells with the
innate ability to target and kill major histocompatibility
complex (MHC) class I negative target cells [1,2]. Therefore
NK cells provide host surveillance against cells that exhibit
loss or down-regulation of MHC Class I such as virally
infected or transformed cells [3–5], and they are therefore
recognised as having an important role in controlling tumour
growth and metastasis [6,7]. NK cells express two distinct
classes of cell surface receptors, inhibitory and activating
receptors, which enable target recognition and ensure the
appropriate response. Inhibitory receptors, which protect
target cells from cytotoxicity include killer inhibitory receptor
family members (KIR) that recognise human leucocyte
antigen (HLA) family members [8], and CD94/NKG2A-B
heterodimeric receptors that specifically recognise HLA-E
[9]. On the other hand, there are a variety of activating
receptors which induce cell cytotoxicity and include natural
cytotoxicity receptors (NCR) (i.e. NKp30, NKp44, NKp46
and NKp80) [10], NKG2D [11], KIR2DS [12], 2B4 [13],
DNAM-I [14], NTB-A [15] and CD94/NKG2C heterodimer
[16]. NK cell-mediated killing cannot be triggered unless
there is a dominance of activating receptor signals over
inhibitory receptor signals for receptor ligand-mediated
recognition of target cells [17]. Therefore, identification of
factors which can result in elevated levels of activating
ligands on target cells may play an important role in
enhancing regulating NK cell function.
A variety of hyperthermia protocols have been shown to
have different effects on the cytotoxic activity of NK cells (for
review see [18]) but overall these studies indicate a general
increase in NK-mediated cytotoxicity induced by hyperther-
mia in both pre-clinical and clinical studies. Our group has
previously shown that the activity of NK cells against the
human colon carcinoma cell line, Colo205 can be enhanced
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following treatment with mild (fever-range) hyperthermia.
[19]. However, little is known about potential mechanism(s)
by which NK cell function is regulated by temperature.
In response to several different types of stress, cells
increase expression of MHC class I related chain A (MICA)
[20–35] a ligand for NKG2D on NK cells, and we have
previously speculated that this increase in response to thermal
stress could act as an evolutionarily conserved danger signal
that may play a role during febrile states [19,36]. The MICA
core promoter contains heat shock elements that inducibly
bind heat shock factor 1 (HSF1) [21,32]. Many previous
studies have shown that HSF1 acts as a temperature sensitive
transcription factor that regulates heat shock protein expres-
sion following heat shock and other stresses [37]. Fionda et al.
[38] showed that inhibition of (mRNA) HSF1 with shRNA
interference blocks MICA and MICB up-regulation in human
myeloma cell lines and that HSF1 is recruited to MICA/B
promoters by Hsp90 inhibitors. Moreover, HSF1 is increased
in T lymphocytes following mild thermal stress temperatures
of 39 C [39]. In line with these findings, heat shock treatment
up-regulated MICA promoter activity in quiescent
HCT116 colon tumour cells [32]. However, there is little
information on whether HSF1 could be a key regulator
of MICA expression under physiological (fever-range)
temperatures. Thus, in this study we tested whether MICA
might be regulated by HSF1 following mild thermal stress
which in turn, leads to enhanced recognition of target cells by
NK cells.
Materials and methods
Cell lines, NK and human colon cell isolation and
in vitro heating
Colo205 and HT29 human colon adenocarcinoma cell lines,
CT26 colon and B16-F10 melanoma murine cell lines
(ATCC) were propagated in RPMI-1640 medium with
2 mM L-glutamine and 10% FBS. For in vitro heating of
cells, we incubated control cell culture plates at 37 C, and
experimental cell culture plates at 39.5 C for 6 h in a
controlled humidity CO2 incubator.
Human NK cells were isolated from healthy donor
peripheral blood as described before [19]. Briefly, NK cells
were purified by depletion of non-NK cells from peripheral
blood mononuclear cells with magnetic separation using a NK
cell isolation kit (Miltenyi Biotech, Auburn, CA) according to
the manufacturer’s protocol. Cell viability and purity were
found to be over 90% with propidium iodide staining.
For isolation of human colonocytes, approximately 5 cm
long (10 g) samples from normal regions of ascending colon
were collected through Tissue Procurement from recently
deceased patients at Roswell Park Cancer Institute using an
approved protocol and processed within 18 h. Blood and
luminal contents were removed by washing the section with
cold tap water and then the sections were dissected longitu-
dinally and placed in sterile ice-cold RPMI-1640 with
L-glutamine, penicillin/streptomycin and amphotericin B.
Visible fat, necrotic tissue/debris and mucus were removed.
The mucosal layer (top layer, which contains epithelial cells)
was separated from the connective tissue and membranes
(bottom layer) and strips (approximately 4–5 mm) were cut
and placed in Petri dishes and washed with warm Hanks
balanced salt solution (HBSS) with 0.15% DTT to remove
residual matter. Mucosal strips were transferred to a new
container with 200 mL of RPMI-1640 with 1 mM EDTA, 10%
fetal bovine serum (FBS) and antibiotic/antimycotic solution
(RPMI-EDTA-FBS) with a stir bar and stirred at room
temperature at 60 rpm for a minimum of 4 h to release cells
from basal lamina. These isolated colon cells were cultured
as previously described [40], and propagated in epithelial
growth media consisting of RPMI-1640 medium supple-
mented with 5% fibroblast conditioned media, antibiotic/
antimycotic solution (penicillin, streptomycin, amphotericin
B), 2 mM L-glutamine, 10% FBS, insulin (5mg/mL) and
transferrin (5 mg/mL).
Whole body hyperthermia
The systemic heating of mice was carried out in an
incubator (Memmert Model BE500, East Troy, WI). Sterile
cages were preheated to 38.5 C in the incubator. Sentinel
mice bearing tumours and implanted with glass-encased
temperature transponders (BioMedic Data Systems, Seaford,
DE) at least 2 weeks prior to heating were included in each
cage in order to allow monitoring of temperature during the
incubation period. Temperature readings were performed
using a hand-held, non-contact temperature measurement
device. (BMDS Pocket Scanner, Model DAS-5007,
BioMedic Data Systems). Baseline measurements were
taken, mice were injected intraperitoneally with 1 mL sterile
saline and then placed in either a cabinet at room
temperature (controls) or in pre-heated cages in the incuba-
tor (whole body hyperthermia (WBH)). Temperatures of
sentinel mice were taken after 15–30 min and then every
hour for the duration of the WBH. The temperature of the
incubator was adjusted as necessary to maintain a mouse
core temperature 39.5  0.5 C.
Cytotoxicity assays
Cytotoxicity assays were performed using the CytoTox 96
non-radioactive cytotoxicity assay (Promega, Madison, WI)
according to the manufacturer’s instructions as described
before [19]. Briefly, human colon tumour cells were mixed
with purified human NK cells at several dilutions and after
brief centrifugation to bring them in contact, incubated for
6 h. The supernatant was analysed for lactate dehydrogenase
(LDH) release from dead cells and compared to maximum
LDH release from detergent-mediated lysis and spontaneous
LDH release from untreated cells.
Monoclonal antibodies and flow cytometry
For flow cytometric staining, 106 cells were washed twice
with PBS followed by incubation with anti-MICA monoclonal
antibody (mAb) (Immatics Biotechnologies, Tubingen,
Germany), anti-HLA-ABC mAb (BD Biosciences
Pharmingen, San Jose, CA), or isotype control antibodies
for 30 min. on ice. They were then washed twice with
sterile PBS, and stained with PE conjugated secondary
antibody (BD Biosciences Pharmingen) for 20 min on ice.
Finally, cells were washed twice with PBS and fixed with
























































freshly prepared 2% paraformaldehyde in PBS, and analysed
with FACScan flow cytometer (BD Biosciences, San Jose,
CA) and FCS Express 3 software (De Novo Software,
Los Angeles, CA).
Immunohistochemistry
Frozen sections 6–8 mm thick of tumours isolated from mice
were air-dried overnight and fixed in cold acetone for 10 min.
Slides were washed with PBS/Tween 20 (0.5% v/v) and
endogenous peroxidase and biotin was blocked with 0.3%
hydrogen peroxide for avidin/biotin treatments. Sections were
treated with 0.03% casein before treatment with goat anti-
mouse NKp46/NCR1 antibody (AF2225, R&D Systems
Minneapolis, MN) diluted 1:500 in Dako antibody diluent
(Carpinteria, CA) for 1 h. After washing with PBS/Tween
three times, and with PBS once, sections were treated
with secondary antibody (1:250 dilution of biotinylated
horse anti-goat antibody from Vector Laboratories,
Burlingame, CA). Sections were washed three times with
PBS-Triton X100 (0.2% v/v) and incubated with streptavidin-
HRP followed by the ImmPACT DAB substrate (Vector
Laboratories). Sections were counter-stained with
Haematoxylin, dehydrated with gradual washes of ethanol
and xylene and mounted with Permount mounting media
(Fisher Scientific, Pittsburg, PA), examined and photographed
with an Olympus BX40 microscope mounted with a Hitachi
HV-C20 CCD camera.
RNA preparation and quantitative real-time PCR
procedure
(mRNA) MICA, HSF1 and HSP70 were analysed by reverse
transcription and PCR analysis as well as quantitative real
time PCR. RNA from tumour tissue homogenised in lysis
buffer was extracted using RNeasy Mini Kit (Qiagen,
Valencia, CA) and quantified by measuring absorbance at
260 and 280 nm using GeneQuant RNA/DNA Calculator
(Pharmacia/Pfizer, New York). cDNA was prepared as
described before [19]. 18S ribosomal RNA (18S) was used
as an internal control in quantitative PCR experiments where
FastStart Universal SYBR Green Master mix was used (Roche
Diagnostics, Mannheim, Germany). Briefly, SYBR Green
Master Mix containing SYBR Green dye, FastStart Taq DNA
polymerase, dNTPs, passive reference (ROX) and buffer
components, were mixed with MICA reverse (50-CATGGATC
TCACAGACCCTAATCT-30) and forward (50-GGATGACCC
TGGCTCATATCA-30), HSF1 reverse (50-GAGATCAGGAA
CTGAATGAGC-30) and forward (50-AAGTACTTCAAGCA
CAACAACAT -30), or HSP70 reverse (50-GCGATCTCCTTC
ATCTTGGT -30), forward (50-AAGGTGGAGATCATCGCC
AA -30) primers, cDNA, and water according to the manu-
facturer’s protocols. Amplifications were performed in 96-
well QRT-PCR plates (Axygen Scientific, Union City, CA)
using an ABI Prism 7900HT Sequence Detection System
(Applied Biosystems, Foster City, CA). Fold change in
relative signal was determined using the 2DDCt formula.
When necessary, PCR products were analysed with 1.5%
agarose gel electrophoresis and ethidium bromide staining.
Images of the gels were obtained with a BioDoc-It
Transilluminator System (UVP, Upland, CA).
TUNEL assay
Apoptosis in tumour sections was detected by staining
sections of frozen tissue in Tissue-Tek OCT blocks for
TUNEL assay using MEB-STAIN Apoptosis Kit Direct
(MBL, Woburn, MA) according to the manufacturer’s
instructions. Briefly, 6-mm frozen sections were prepared,
fixed in 4% paraformaldehyde and washed with PBS. Next,
they were treated with TdT enzyme and FITC conjugated
dUTP. Tissue sections were mounted on slides with
Vectashield mounting media containing DAPI (Vector
Laboratories). Positive control sections were treated with
DNase I solution (Sigma-Aldrich, St Louis, MO). Sections
were examined with a Zeiss Axioskop2 MOT fluorescent
microscope mounted with a SPOT camera (Diagnostic
Instruments, Sterling Heights, MI).
Silencing of HSF1
HSF1 in Colo205 cells was silenced using Silencer pre-
designed siRNAs (Ambion, Austin, TX). The 21-mer siRNA
sequences are as follows: 115674 sense 50-GCAACAGAAAG
UCGUCAACtt-30, antisense 50-GUUGACGACUUUCUGUU
GCtg-3; 3134 sense 50-AUAGUCAGAAUUGUAUUUUtt-30,
antisense 5’-AAAAUACAAUUCUGACUAUtg-30. Five mil-
lion cells were transfected with 5 mg HSF1 or control siRNA
using a Nucleofector Kit T (Amaxa Biosystems, Gaithersburg,
MD), according to the manufacturer’s instructions. The cells
were harvested 72 h after transfection for further experiments.
Cycloheximide treatment
Colo205 cells were divided into four groups: the first group
was treated with DMSO for the duration of 12 h at 37 C. The
second group was treated with DMSO for 6 h at 37 C and
with cycloheximide (5 mg/mL) for another 6 h at 37 C. The
third group was treated with DMSO for 6 h at 39.5 C and
then with cycloheximide (5 mg/mL) for another 6 h at 37 C.
The fourth group was treated with DMSO for 6 h at 39.5 C
and for another 6 h at 37 C. Cell surface MICA was measured
at 0, 6, 7, 8, 9 and 12 h with flow cytometry.
Luciferase reporter assays of MICA promoter
Luciferase reporter activity under the MICA promoter was
determined following transfection into Colo205 cells using a
Nucleofector Kit T, according to the manufacturer’s instruc-
tions. One million cells were transfected with 1 mg luciferase
reporter plasmid and 0.1 mg of pRL-CMV Renilla vector, for
standardisation of transfection efficiency. The cells were
harvested 72 h after transfection. Luciferase assays were
performed using a dual luciferase reporter assay system
(Promega) according to the manufacturer’s protocol.
Transcriptional activity was measured in a Fluoroskan
Ascent FL luminometer (Thermo Electron Corporation,
Vantaa, Finland).
MICA promoter plasmids were constructed by cloning the
minimal MICA promoter into pGL3.basic vector (Promega),
named pGL3.MICA. HSF1 binding site mutations were
performed on the pGL3.MICA plasmid using a QuikChange
Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA).
Mutations were confirmed by standard sequencing protocols.
























































The mutated plasmid was designated pGL3.HSRE. A reporter
plasmid carrying the Simian virus 40 (SV40) promoter and
enhancer was used as positive control (pGL3.SV40).
Statistics
All data were analysed using GraphPad Prism 5.0 (GraphPad
Software, San Diego, CA) statistical analysis software.
ANOVA analysis was used in tests involving more than two
variables. T-test with Welch‘s correction was used for the
analysis of significance between two unmatched experimental
groups. Significance was accepted over 95% confidence.
Results
Tumour cell apoptosis and the presence of NK cells in
the tumour microenvironment is increased after mild
systemic thermal stress
Previous studies from our group demonstrated increased
numbers of leucocytes, including NK cells, in the tumour
microenvironment of tumour-bearing SCID mice treated with
fever-range whole body hyperthermia (WBH) [41]; moreover,
in that study we also observed evidence of increased
apoptosis which we hypothesised was due to the increased
presence of NK cells in the tumour microenvironment. We
have confirmed this information using other model systems
here. Using a patient-derived colon tumour xenograft we
again looked for changes in apoptosis following mild WBH.
Tumours from unheated mice showed a low level of apoptosis
(determined using the TUNEL assay [42]) with only a
few apoptotic cells visible at normothermic conditions
(Figure 1A). However, within a day after WBH we observed
evidence of increased TUNEL positive cells in tumour
sections (Figure 1B). In another experiment, using CT26
cells grown as a tumour in BALB/c mice, we found that WBH
resulted in an increase in the number of cells bearing a marker
for NK cells, NKp46 [10]. Representative photomicrographs
from normothermic and hyperthermic BALB/c mice carrying
CT26 tumours are shown in Figures 1(C and 1D), respectively
Since NK cells are the primary cytolytic effector cells in
the SCID mouse model, these anatomical and immunohis-
tochemistry data support our hypothesis that mild heating
may, in some way, stimulate increased NK cell-mediated anti-
tumour activity. Additionally, we and others have also shown
previously that in vitro heat treatments can enhance NK cell
cytotoxicity [18,19] and that this effect coincides with
increased surface expression of MICA on the human colon
adenocarcinoma cell line Colo205 [19]. Collectively, these
observations support the hypothesis that NK cells are
sensitive to thermal stress and that by better understanding
the mechanisms underlying this sensitivity, we may better
target these cells for clinical hyperthermia applications.
Thus, next we examined in greater molecular detail
Figure 1. Whole body hyperthermia (WBH) increases the numbers of NK cells and apoptotic cells in colon tumours. (A, B) Localisation of apoptotic
cells by TUNEL assay in a patient tumour xenograft from control (A) or WBH treated (B) SCID mice (arrows, original mag. 40X). (C, D)
Immunohistochemical localisation of NKp46þ cells in CT26 tumours from control (C) and WBH treated (D) mice at 24 h post-WBH (arrows, original
magnification 10).
























































the mechanism by which MICA expression could be
regulated by mild thermal stress and focused largely on
the role of HSF1.
Thermal enhancement of NK cytotoxicity against
colon carcinoma cells is dependent upon
HSF1-dependent induction of MICA
We have previously shown that mild heating in vitro results in
a significant increase in surface expression of MICA on cells
from the human Colo205 cell line [19]. To determine whether
the increase in MICA following thermal stress was due to
HSF1, Colo205 cells were transfected with two constructs of
(mRNA) HSF1 siRNA to silence the transcription factor.
Control transfectants included negative control siRNA at the
highest concentration used for (mRNA) HSF1 silencing.
HSF1 is endogenously present in Colo205 cells, and was
suppressed to a quarter of the levels in controls by siRNA-
mediated silencing as determined by western blotting (data
not shown). Transfected Colo205 cells were exposed to mild
(fever-range) thermal stress (39.5 C) for 6 h or kept at
normothermic (37 C) temperature in vitro. Analysis for
(mRNA) HSF1 carried out with quantitative RT-PCR at 48 h
showed that silencing with (mRNA) HSF1 siRNA resulted in
a five-fold decrease in thermal stress-inducible HSF1 message
(Figure 2A) correlating with the reduced protein expression.
The effect of HSF1 reduction on surface MICA expression
by Colo205 cells was examined with flow cytometry
(Figure 2B). Colo205 cells were treated with thermal stress
(39.5 C) for 6 h and then analysed for MICA expression. We
observed an overall reduction of thermally enhanced surface
MICA expression on Colo205 cells after transfection with
both (mRNA) HSF1 siRNA constructs at all concentrations.
We next asked whether silencing of HSF1 message would
affect susceptibility of the Colo205 cells to NK cell killing.
NK cells were isolated from three healthy human donors.
Colo205 cells transfected with (mRNA) HSF1 siRNA were
used as target cells in NK cell cytotoxicity assays. Transfected
cells were either held at (37 C) or treated with mild thermal
stress (39.5 C) for 6 h in vitro as above. Cytotoxicity assays
showed that (mRNA) HSF1 silencing resulted in a significant
decrease in NK cell-mediated cytotoxicity at higher NK cell
Figure 2. Silencing of (mRNA) HSF1 in tumour cells results in decreased MICA expression and impaired thermally enhanced cytotoxicity by human
NK cells. Colo205 cells were transfected with two different siRNA constructs against HSF1 (3134 and 115674) at two different concentrations 3 pg/cell
(g) and 5 pg/cell (œ), or with control siRNA at 5 pg/cell ( ). Cells were either treated with hyperthermia (39.5 C) for 6 h, heat-shock (42 C) for 1 h
or kept at normothermic temperatures. (A) The (mRNA) HSF1 message level was detected with quantitative real-time PCR, 48 h after transfection. The
results were normalised to 18 S rRNA expression. (B) The MICA expression on the surface of transfected cells was analysed by flow cytometry. Dotted
line indicates control levels of (mRNA) HSF1 message or MICA surface levels at normothermic temperatures. (C) Thermally enhanced cytotoxicity of
human NK cell was reduced when (mRNA) HSF1-silenced Colo205 cells were used as targets in vitro. Target cells were treated with control siRNA (g
and œ) or (mRNA) HSF1 siRNA ( and g) at hyperthermic (39.5 C, 6 h) (œ and g), or normothermic control temperatures (37 C) (g and ). The
data were representative of three donors for cytotoxicity assays (n¼ 3). *p 0.05 compared to the corresponding normothermic group. yp 0.05
compared to the corresponding control siRNA using unpaired t-test with Welch’s correction.
























































to target ratios (Figure 2C). These findings confirm our
earlier report that thermal stress enhances NK activity and
up-regulates MICA expression on tumour cells and further
suggest that HSF1 plays a critical role in the induction of
MICA on Colo205 cells.
Mutation of the HSF1 binding site results in the loss of
thermally enhanced activity of the MICA promoter
To further test the role of HSF1 in thermal induction of
MICA, the minimal MICA promoter described in [32] was
cloned into the pGL3 luciferase reporter construct. HSF1
binding sites in the promoter were mutated by site-directed
mutagenesis (Figure 3A). Promoter constructs were trans-
fected into Colo205 cells; the cells were then subjected to
thermal stress (Figure 3B). Mild thermal stress induced a
significant increase in MICA promoter activity as measured
by increased luciferase activity, and this was abrogated when
the HSF1 binding site was mutated. Thermal stress had no
effect on luciferase activity in cells transfected with either a
promoter-less construct (pGL3) or when luciferase expression
was driven by SV40 (pGL3.SV40).
MICA stability on tumour cell surface after thermal
stress depends on thermally enhanced MICA synthesis
Previously we observed an increase in MICA message within
3 h after thermal stress in vitro, followed by an observed
increase in MICA surface expression at 6 h [19].
Cycloheximide, as an inhibitor of eukaryotic protein signal-
ling, can block translational elongation; therefore, we used it
to determine the extent of de novo translation-independent
increase in surface MICA after mild thermal stress. This
experiment tests whether the thermal stress-induced increase
in cell surface MICA is due to elevated transcription/
translation, or is perhaps due to other events, such as cell
membrane changes as we previously observed [19]. Since
treatment with cycloheximide following thermal stress leads
to a faster loss of MICA surface expression than seen using
DMSO alone following thermal stress (Figure 4), the
prolonged increase in MICA surface expression following
thermal stress likely requires continual protein synthesis.
Whole body hyperthermia results in increased MICA in
tumour cells in vivo
Our previous results demonstrated that in vitro thermal stress
results in an increase in MICA levels on tumour cells, which
correlates with enhanced NK cell cytotoxicity [19]. To ask
whether similar results would occur in vivo, i.e., in tumour
cells in mice treated with WBH, SCID mice bearing Colo205
(Figure 5A), HT29 (Figure 5B) and four different patient-
derived colon tumour xenografts (Figure 5C) were treated
with WBH. Colo205-derived tumours were found to have
up-regulated message levels for MICA, HSF1 and Hsp70 after
WBH (Figure 5A), while HT29-derived tumours only showed
an increase in Hsp70 (Figure 5B). Of the four patient
xenografts, MICA was increased in two of the earlier passage
tumours, 16115 (second passage) and 16460 (third passage),
but not in two late passage tumours 13391 (17th passage) and
15053 (sixth passage).
Previous kinetic studies of MICA expression with thermal
stress showed that transcriptional regulation of MICA mes-
sage starts as early as 3 h in vitro [19]. Therefore we
investigated the kinetics of MICA message in Colo205 and
HT29 tumours within 24 h after WBH. (mRNA) MICA levels
steadily increased in the Colo205 tumours up to 24 h after
WBH (Figure 5D). On the other hand, MICA message levels
did not increase over the course of 24 h in HT29 tumours
(Figure 5E), in agreement with the lack of increase in MICA
message expression at 6 h in (Figure 5B). Mouse MICA
orthologue, Rae1, mRNA expression in CT26 tumours
occurred at 12 h post-WBH (Figure 5F) which is slightly
slower than the analogous response in Colo205.
Normal human colonocytes do not up-regulate MICA
after thermal stress
We examined whether mild thermal stress also enhanced
surface expression of MICA by normal human colonocytes.
Colonocytes isolated from colon samples were treated with
mild thermal stress at 39.5 C for 6 h in vitro, labelled for
surface MICA protein expression and pan-HLA (since
thermally mediated NK cell cytotoxicity against these cells
Figure 3. Mutation of HSF1 binding site results in the loss of thermally
enhanced activity of MICA promoter. (A) Schematic representation of
plasmid constructs containing luciferase reporter gene driven by MICA
promoter. Basic pGL3 construct (pGL3), pGL3 construct carrying the
MICA promoter (pGL3.MICA), point mutations in HSRE in MICA
promoter (pGL3.HSRE), and positive control construct carrying an
SV40 promoter and enhancer (pGL3.SV40). (B) Colo205 cells were
transfected with the reporter constructs described in (A) and treated at
normothermic (g) or hyperthermic (œ) temperatures for 6 h. Relative
luciferase activity was detected by dual luciferase reporter assay and
normalised to Renilla luciferase activity as transfection control.
*p 0.05 compared to the corresponding normothermic group.
























































could potentially change if surface MHC Class I expression is
altered) and then compared to Colo205 cells treated under the
same conditions. Although MICA and HLA are expressed in
normal colonocytes, we observed no change in the expression
of either following mild thermal stress (Figure 6A). This
complements our previous studies which showed that there
was no change in HLA expression on tumour cells following
thermal stress [19].
Discussion
The initial data presented here (Figure 1) provides some
additional descriptive evidence that following systemic
heating in vivo, tumour cell apoptosis (in a patient tumour-
derived xenograft model) increases (Figures 1A and B) and,
in a different tumour model, that there is an increase in the
presence of NK cells, as detected by the marker NKp46þ cells
within the tumour microenvironment (Figure 1C and D).
NKp46 has recently been validated as a human NK cell
marker in gut-associated tissues, including its association with
innate lymphoid cells (ILC) in mice [43]. These observations,
combined with our previous studies demonstrating that NK
cell cytotoxicity is enhanced by mild heating, provided an
impetus to learn more about how mild heating affects tumour
cell sensitivity to NK cells. Thus, the major goal of this study
was to study effects of mild heating on tumour cell expression
of the non-classical MHC-like molecule, MICA, which is a
major ligand for NKG2D on NK cells, and more specifically,
to determine whether any increased expression of MICA on
the surface of tumour cells following mild heat exposure
might be regulated by HSF1.
We demonstrated that down-regulation of (mRNA) HSF1
by use of two different siRNAs resulted in decreased HSF1
message, accompanied by down-regulation of thermally
enhanced, but not endogenous, MICA levels. This confirms
that the effect of thermal stress on MICA expression is at the
transcriptional level through the activity of HSF1 (Figure 2).
Consistent results using two different siRNA constructs
support that HSF1 silencing-mediated (mRNA) MICA
down-regulation is not a non-specific, off-target effect
(Figure 2A,B). Importantly, MICA message down-regulation
resulted in decreased NK activity against Colo205 tumour
cells in vitro (Figure 2C). The observed decrease in NK-
mediated cytotoxicity with (mRNA) HSF1 siRNA at
normothermic conditions suggests a role for HSF1 in NK
cell function under normothermic conditions. While a role for
other activating ligands that might be present on Colo205 cell
surface was not suspected, since NKG2D/MICA blocking
antibodies were previously shown to block endogenous and
thermally enhanced cytotoxicity in this model [19], our data
does not exclude a possible role for other surface molecules
that might be altered with thermal stress.
Promoter reporter assays revealed an up-regulation of
MICA promoter activity with thermal stress which is dependent
on the presence of intact HSF1 binding site in the promoter
(Figure 3). These results are in agreement with previous studies
demonstrating the role of HSF1 binding site in MICA promoter
in quiescent HCT116 colon tumour cells with heat shock [32].
However, a correlation between HSF1-mediated transcrip-
tional regulation of the MICA gene at mild thermal stress
temperatures has not been previously described. The observed
increase in luciferase activity at control temperatures when the
HSF1 binding site is mutated suggests that MICA expression
might be suppressed by HSF1 under normothermic conditions.
However, these arguments would have been greatly supported
by the use of a chromatin immunoprecipitation (ChIP) assay
showing direct HSF1 binding to the MICA promoter.
We have previously observed a transient increase in mild
thermal stress-enhanced NK cell cytotoxicity of Colo205
cells, which regresses to non-significant levels of cytotoxicity
compared to control temperatures within 24 h in vitro
(unpublished results). Here we show that thermally enhanced
surface MICA expression on cell surface is dependent on
sustained MICA synthesis, where disruption leads to faster
levels of decay from the cell surface (Figure 4). Our results
indicate that MICA cell surface kinetics follow ‘one-phase
exponential decay’, with significantly enhanced MICA levels
on the cell surface without cycloheximide. While thermal
stress clearly helps to regulate the transcription of MICA, the
precise mechanisms by which MICA trafficking to the cell
surface might be affected requires further research. In
addition, it is important to remember that shedding of
MICA molecules from the tumour cell surface occurs through
metalloproteinase activity [44,45]; however, we have not yet
addressed this issue under thermal stress conditions.
We also tested whether systemic heating in vivo could up
regulate (mRNA) MICA expression, i.e., in Colo205 and
HT29 tumour cells growing in mice (Figure 5). We consist-
ently observed an up-regulation of MICA message in Colo205
tumours following WBH, averaging a 4.2-fold change
compared to tumours in mice maintained at normothermia.
While Colo205 tumours in SCID mice show a consistent
increase of MICA message levels up to 24 h following WBH,
HT29 cells do not [19]. However, HSP70 up-regulation with
thermal stress is still intact in HT29 cells, albeit less than
Colo205 cells. The role of HSF1 in regulation of HSP70 and
MICA message may vary between different tumour cells, and
the basis for these differences should be investigated.
Several studies have shown that classical MHC class I
molecule expression on cell surface is the major signal for
‘self’ recognition by the immune system, and is also a major
deterrent for NK cell-mediated cytotoxicity [46,47]. Previous
reports for endogenous expression of MICA on human
Figure 4. Cycloheximide inhibits induction of MICA by thermal stress
in Colo205 cells. Colo205 cells were treated with mild thermal stress at
39.5 C (m, H) or at 37 C (˙, ) with DMSO for 6 h in vitro, followed by
cycloheximide (5 mg/mL in the culture medium) (H, ) or DMSO, the
solvent used for cycloheximide (m, ˙) at normothermic temperatures.
Cell surface MICA expression was detected with flow cytometry.
























































colonocytes [11,48], combined with the importance of HLA
expression for limiting NK cell-mediated killing, led us to
investigate the expression of HLA and MICA levels on
colonocytes isolated from human donors and then treated
in vitro with hyperthermia. Although we have observed
relatively low expression of MICA message in normal
colonocytes, our study suggests that mild heat stress does
not lead to significant changes in MICA or HLA (A, B, C)
levels (Figure 6). This evidence for some specificity of heat
stress on MICA expression on tumour cells versus normal
cells requires further analysis to test whether there are
changes in the transcriptional control of MICA expression
during colon cancer progression.
This report has highlighted HSF1-mediated MICA expres-
sion on tumour cells as a potential molecular mechanism to
explain the enhancement of NK cell cytotoxicity against
tumours following mild thermal stress. However, there are
other studies suggesting alternative regulation pathways for
MICA regulation in the literature, mainly through other
transcription factors. For example, a recent study shows that
NF-kB may also be a transcription factor that controls MICA
expression. Lin et al. [49] demonstrated that the TNF-
a-mediated MICA up-regulation on human umbilical vein
endothelial cells is through NF-kB. In this model NF-kB acts
on the 130 bp of MICA transcription start site, overlapping
with heat shock response elements (HSRE). We also
Figure 5. Response of colon cell lines and patient tumour xenografts to mild thermal stress. Colo205 (A), or HT29 (B) tumour bearing SCID mice were
treated with whole body hyperthermia (WBH) at 39.5 C for 6 h in vivo. Fold change of MICA, HSF1 and HSP70 mRNA in the tumours compared to
18 S RNA or levels in tumours from control mice was measured by quantitative RT-PCR and calculated against 18 S RNA, using triplicate wells. The
data shown represent the mean SD (n	 3) of three experiments. (C) Colon tumours from four patients were implanted into SCID mice and treated
with WBH. MICA mRNA expression was detected by qPCR and fold change determined compared to untreated controls (D, E) Kinetics of MICA
mRNA levels in Colo205 and HT29 xenografts respectively at 3, 6, 12 and 24 h after WBH. (F) Kinetics of the murine MICA orthologue, Rae1 mRNA
expression in CT26 tumours in BALB/c mice œ hyperthermic, g normothermic.
























































investigated this region in our study. Lin et al. [49] found that
TNF-a-mediated MICA up-regulation is inhibited with an
inactive form of HSF1 (lacking a transactivation domain).
These results further support our observations. Lin et al.
further suggested a competition between NF-kB and HSF1 for
the MICA promoter binding site, which is found to be
responsive to heat shock (42 C, 1 h). However Andresen et al.
[50] reported that histone deactylase inhibitors cause an
increase in surface MICA/B expression in Jurkat T cells,
which is completely abrogated by intracellular calcium
depletion, independent of NF-kB but dependent on transcrip-
tion factor Sp1. They identified 115 to 84 of MICA
promoter as the strong regulatory region in Jurkat T cells. In
our colon tumour models, we have not determined whether
the effect of HSF1 on MICA expression is independent of NF-
kB or TNF-a. Luo et al. [51] stated that hypoxia inducible
factor (HIF-1) regulates MICA expression in human renal
proximal tubular epithelial cells HK-2. This observation of
MICA up-regulation under hypoxic stress provides further
support to our earlier observation [19] of its up-regulation
under thermal stress. Another transcription factor identified in
MICA transcriptional regulation is STAT3 [52]. Studies
suggest that STAT3 negatively regulates MICA after it was
observed that there was increased expression of MICA
following STAT3 inhibition and direct binding of STAT3 on
MICA promoter. MICA induction in mesenchymal stem cells
after heat shock (45 C, 1 h) is also prevented with constitu-
tive activation of STAT3, suggesting that STAT3 might also
play a role in thermal regulation of MICA up-regulation.
Clearly, the role of other transcription factors in thermal
modulation of NK cell activity requires further investigation.
Overall, the data shown here provides additional support
for the notion that mild thermal stress can enhance the activity
of immune cells such as NK cells. However, at the present
time there are no clinical studies which have correlated MICA
expression on tumour cells with patient survival following
hyperthermia treatment and this is clearly an important gap in
the field. The studies reported here predict that some patients
may benefit from mild hyperthermia treatment through
thermally enhanced tumour cell expression of MICA and
increased anti-tumour NK cell cytolytic function. However,
our data also reveals significant variation among tumour cells
in terms of MICA expression following heating, suggesting
that not all patients may benefit. Clearly new biomarkers or
correlative studies which can link heat-induced changes in
NK cell activity, and/or tumour cell sensitivity, could be very
helpful in predicting which patients may benefit most by
receiving clinical hyperthermia.
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